国家药监局再次应急审批新型冠状病毒核酸检测试剂

2020-02-01 余静英 央视新闻

1月31日,国家药品监督管理局根据《医疗器械应急审批程序》,按照“统一指挥、早期介入、随到随审、科学审批”的原则和确保产品安全、有效、质量可控的要求,在已批准6家企业6个产品基础上,再次批准1家企业1个新型冠状病毒2019-nCoV核酸检测试剂盒(荧光PCR法)产品,进一步扩大新型冠状病毒核酸检测试剂供给能力,全力服务疫情防控需要。截至目前,已应急审批7个新型冠状病毒核酸检测试剂。国家药监局将根据

1月31日,国家药品监督管理局根据《医疗器械应急审批程序》,按照“统一指挥、早期介入、随到随审、科学审批”的原则和确保产品安全、有效、质量可控的要求,在已批准6家企业6个产品基础上,再次批准1家企业1个新型冠状病毒2019-nCoV核酸检测试剂盒(荧光PCR法)产品,进一步扩大新型冠状病毒核酸检测试剂供给能力,全力服务疫情防控需要。截至目前,已应急审批7个新型冠状病毒核酸检测试剂。

国家药监局将根据疫情防控需要,继续做好相应产品应急审批工作。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1934649, encodeId=2c3f193464969, content=<a href='/topic/show?id=325762560c5' target=_blank style='color:#2F92EE;'>#检测试剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62560, encryptionId=325762560c5, topicName=检测试剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Feb 02 18:47:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1997764, encodeId=7d0c199e764ea, content=<a href='/topic/show?id=74816216e2e' target=_blank style='color:#2F92EE;'>#核酸检测试剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62167, encryptionId=74816216e2e, topicName=核酸检测试剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f54230, createdName=xlysu, createdTime=Tue Apr 14 16:47:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301704, encodeId=9dc91301e0428, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Mon Feb 03 06:47:00 CST 2020, time=2020-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429244, encodeId=debd1429244f1, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Mon Feb 03 06:47:00 CST 2020, time=2020-02-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1934649, encodeId=2c3f193464969, content=<a href='/topic/show?id=325762560c5' target=_blank style='color:#2F92EE;'>#检测试剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62560, encryptionId=325762560c5, topicName=检测试剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Feb 02 18:47:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1997764, encodeId=7d0c199e764ea, content=<a href='/topic/show?id=74816216e2e' target=_blank style='color:#2F92EE;'>#核酸检测试剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62167, encryptionId=74816216e2e, topicName=核酸检测试剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f54230, createdName=xlysu, createdTime=Tue Apr 14 16:47:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301704, encodeId=9dc91301e0428, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Mon Feb 03 06:47:00 CST 2020, time=2020-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429244, encodeId=debd1429244f1, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Mon Feb 03 06:47:00 CST 2020, time=2020-02-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1934649, encodeId=2c3f193464969, content=<a href='/topic/show?id=325762560c5' target=_blank style='color:#2F92EE;'>#检测试剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62560, encryptionId=325762560c5, topicName=检测试剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Feb 02 18:47:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1997764, encodeId=7d0c199e764ea, content=<a href='/topic/show?id=74816216e2e' target=_blank style='color:#2F92EE;'>#核酸检测试剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62167, encryptionId=74816216e2e, topicName=核酸检测试剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f54230, createdName=xlysu, createdTime=Tue Apr 14 16:47:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301704, encodeId=9dc91301e0428, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Mon Feb 03 06:47:00 CST 2020, time=2020-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429244, encodeId=debd1429244f1, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Mon Feb 03 06:47:00 CST 2020, time=2020-02-03, status=1, ipAttribution=)]
    2020-02-03 xuyu
  4. [GetPortalCommentsPageByObjectIdResponse(id=1934649, encodeId=2c3f193464969, content=<a href='/topic/show?id=325762560c5' target=_blank style='color:#2F92EE;'>#检测试剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62560, encryptionId=325762560c5, topicName=检测试剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sun Feb 02 18:47:00 CST 2020, time=2020-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1997764, encodeId=7d0c199e764ea, content=<a href='/topic/show?id=74816216e2e' target=_blank style='color:#2F92EE;'>#核酸检测试剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62167, encryptionId=74816216e2e, topicName=核酸检测试剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f54230, createdName=xlysu, createdTime=Tue Apr 14 16:47:00 CST 2020, time=2020-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301704, encodeId=9dc91301e0428, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Mon Feb 03 06:47:00 CST 2020, time=2020-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429244, encodeId=debd1429244f1, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Mon Feb 03 06:47:00 CST 2020, time=2020-02-03, status=1, ipAttribution=)]

相关资讯

警示!医疗器械大检查,药监局发布40条缺陷

前车之鉴,后事之师 。以下的40余条缺陷与过失应作为借鉴,以当警惕。

填补56年空白:国家药监局批准最佳治疗高钾血症创新药上市

1月6日, 记者从阿斯利康获悉,其新型口服降钾药物利倍卓(通用名:环硅酸锆钠散)获得中国国家药品监督管理局(NMPA)的上市批准,用于治疗成人高钾血症。利倍卓是该治疗领域首个在中国上市的创新药物,填补了约56年的空白期。据介绍,上一代的高钾血症治疗方法是1964年获批的静脉补钙,此后一直未有创新药物获批进入中国市场。2019年上半年,环硅酸锆钠散因独特的作用机制与临床疗效,可帮助高钾血症患者解决未

国家药监局:统一5项标准 共建疫苗信息化追溯体系

近日,国家药品监督管理局发布有关疫苗追溯标准规范的解读,对我国疫苗追溯标准的内容、适用范围等问题进行了回答。一、标准的编制背景、依据和适用范围1.什么是疫苗信息化追溯体系?答:为贯彻落实药品追溯相关法规,国家药监局规划实施药品信息化追溯体系,按照药品剂型、类别分步推进。根据《中华人民共和国疫苗管理法》中关于国家实行疫苗全程电子追溯制度的要求,疫苗作为重点产品应率先建立疫苗信息化追溯体系。疫苗信

国家药监局:去年可疑医疗器械不良事件超40万份

国家药品监督管理局11月4日在官网发布由国家药品不良反应监测中心编撰的《国家医疗器械不良事件监测年度报告(2018年)》。该报告显示,2018年,全国医疗器械不良事件监测信息系统接收可疑医疗器械不良事件报告406974份,较2017年增长8.19%,其中,138份报告伤害程度为“死亡”。我国每百万人口平均可疑医疗器械不良事件报告数305份,与2017年相比增长23份。公开资料显示,医疗器械不良事件

国家药监局拟出台疫苗药品配套规章,源头防范质量风险

国家药监局拟出台疫苗药品配套规章,确保疫苗管理法等法律法规落地实施。10月17日,最高人民检察院发布《全国检察机关、市场监管部门、药品监管部门落实食品药品安全“四个最严”要求专项行动工作方案》,通报近年工作情况和专项行动主要内容和工作要求。在疫苗安全上,国家药监局要求强化疫苗药品监管执法,严厉打击疫苗药品领域违法行为。国家药品监督管理局政策法规司副司长吴利雅表示,要统筹运用检查、检验、监测、投诉举

国家药监局:不存在所谓的“械字号面膜”

械字号面膜、医美面膜......这些产品被宣称比普通面膜标准高、功效强、更安全,更适合消费者使用,但这到底是不是真的呢?日前国家药监局发布科普文章提醒消费者要警惕面膜消费陷阱!不存在所谓的“械字号面膜”所谓“械字号面膜”,其实是医用敷料,属于医疗器械范畴。医用敷料可以与创面直接或间接接触,具有吸收创面渗出液、支撑器官、防粘连或者为创面愈合提供适宜环境等医疗作用。按照医疗器械管理的医用敷料,可以分为